Before performing these experiments, we established KCNAB2 gene expression levels in HT29 and SW480 CRC commercial cell lines, which were clearly overexpressed in CRC cells compared to healthy colonocytes (Figure S1). The gene discussed is KCNAB2; the disease is colorectal carcinoma.